IP Library Granted Patent US 10,240,173
Granted Patent B2
US 10,240,173 · App. 16/031,492 · Granted Mar 26, 2019

Biosynthesis of forskolin and related compounds

Inventors: Björn Hamberger (Kastrup, DK); Birger Lindberg Møller (Brønshøj, DK); Eirini Pateraki (Vallensbeak Strand, DK); Johan Andersen-Ranberg (Copenhagen, DK); Niels Bjerg Jensen (Kastrup, DE)
Assignees: University of Copenhagen; Danmarks Tekniske Universitet; Evolva SA
C12P17/06C12N9/0071C12P5/007C12Y114/14001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,240,173
App. No.
16/031,492
Granted
Mar 26, 2019
Kind
B2
Abstract

The invention described materials and methods for producing oxidized 13R-MO, such as forskolin. In particular, the invention describes P450s involved in oxidation of 13R-MO including CYP76AH8, CYP76AH11, CYP76AH15, CYP76AH17, CYP71D381 and CYP76AH9. Host organisms expressing one or more of these P450s are useful in the production of oxidized 13R-MO.

Claims (17)

1. A host organism, comprising a heterologous nucleic acid encoding an enzyme capable of catalysing hydroxylation of 13R-manoyl oxide (13R-MO) and/or an oxidised 13R-MO derivative at the 11-position, wherein the oxidised 13R-MO carries a —H at the 11-position; and/or catalysing oxidation of a hydroxyl group to form an oxo-group at the 11-position of 11-hydroxyl-13R-MO and/or an oxidised 11-hydroxyl-13R-MO, wherein the enzyme comprises:

(a) CYP76AH8 having at least 90% identity to the amino acid sequence set forth in SEQ ID NO:1;

(b) CYP76AH17 having at least 90% identity to the amino acid sequence set forth in SEQ ID NO:10;

(c) CYP76AH15 having at least 90% identity to the amino acid sequence set forth in SEQ ID NO:11; and/or

(d) CYP76AH11 having at least 90% identity to the amino acid sequence set forth in SEQ ID NO:2.

2. The host organism of claim 1 , further comprising:

(a) a heterologous nucleic acid encoding an enzyme capable of catalysing hydroxylation of 13R-MO and/or oxidised 13R-MO at the 1-position, wherein the oxidised 13R-MO carries a —H at the 1-position;

(b) a heterologous nucleic acid encoding an enzyme capable of catalysing hydroxylation of 13R-MO and/or oxidised 13R-MO at the 6-position, wherein the oxidised 13R-MO carries a —H at the 6-position;

(c) a heterologous nucleic acid encoding an enzyme capable of catalysing hydroxylation of 13R-MO and/or oxidised 13R-MO at the 7-position, wherein the oxidised 13R-MO carries a —H at the 7-position; or

(d) a heterologous nucleic acid encoding an enzyme capable of catalysing hydroxylation of 13R-MO and/or oxidised 13R-MO at the 9-position, wherein the oxidised 13R-MO carries a —H at the 9-position.

3. The host organism of claim 2 , further comprising at least one heterologous nucleic acid encoding a polypeptide capable of catalysing hydroxylation of 11-keto-13R-manoyl oxide (13R-MO) and/or an oxidised 11-keto-13R-MO derivative at one or more of the positions 1, 6, 7 and/or 9, wherein the polypeptide is CYP76AH11 having at least 95% identity to the amino acid sequence set forth in SEQ ID NO:2.

4. The host organism of claim 2 , further comprising at least one heterologous nucleic acid encoding a polypeptide capable of catalysing hydroxylation of 13R-manoyl oxide (13R-MO) and/or an oxidised 13R-MO at one or more of the positions 1, 6, 7 and/or 9, wherein the polypeptide is CYP71D381 having at least 95% identity to the amino acid sequence set forth in SEQ ID NO:3 or CYP76AH9 having at least 95% identity to the amino acid sequence set forth in SEQ ID NO:4.

5. The host organism of claim 1 , wherein the host organism is a microorganism.

6. The host organism of claim 1 , wherein the microorganism is yeast.

7. The host organism of claim 1 , wherein the host organism is a plant.

8. The host organism of claim 1 , wherein the host organism further comprises a heterologous nucleic acid encoding TPS2 having at least 95% identity to the amino acid sequence set forth in SEQ ID NO:7.

9. The host organism of claim 1 , wherein the host organism further comprises a heterologous nucleic acid encoding TPS3 having at least 95% identity to the amino acid sequence set forth in SEQ ID NO:8 or TPS4 having at least 95% identity to the amino acid sequence set forth in SEQ ID NO:9.

Assignments (3)
MERGER Recorded Jun 27, 2024
From: EVOLVA SA
To: DANSTAR FERMENT AG
Reel/Frame 067863/0857 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2019
From: JENSEN, NIELS BJERG
To: EVOLVA SA
Reel/Frame 048217/0531 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2019
From: HAMBERGER, BJÖRN; MØLLER, BIRGER LINDBERG; PATERAKI, EIRINI; ANDERSEN-RANBERG, JOHAN
To: UNIVERSITY OF COPENHAGEN
Reel/Frame 048217/0534 →
Priority Claims (3)
DK 2014 00057 · Jan 31, 2014 · national
DK 2014 70380 · Jun 23, 2014 · national
DK 2014 70536 · Sep 3, 2014 · national
Continuity (2)
Division 15110795
Related Publication 20190010527A1 · Jan 10, 2019